Professor Jeffery Coller's lab at Johns Hopkins University studies the role of codon optimality in determining the stability of messenger RNA (mRNA). By investigating how the rates at which ribosomes decode mRNA influence its degradation, the lab aims to uncover critical principles of gene regulation. Their research has implications for understanding cancer and viral infections, as these processes can disrupt normal cellular functions and exploit the mechanisms of gene expression.

Tamara O'Connor's lab at Johns Hopkins University focuses on understanding how bacterial pathogens, specifically Legionella pneumophila, utilize host cell organelles called peroxisomes to thrive and evade the immune system. The research aims to uncover new strategies to develop antibiotics that can target these mechanisms to combat infections effectively. By investigating the role of peroxisomes in bacterial growth and survival within host cells, the lab hopes to identify new therapeutic opportunities for treating infections.

Dr. Jiou Wang's lab at Johns Hopkins University focuses on understanding the underlying causes of neurodegenerative diseases like ALS and frontotemporal dementia (FTD). They investigate how genetic factors, particularly a mutation in the C9orf72 gene, lead to neuronal damage. The lab employs a combination of biochemical, molecular, and genetic techniques to explore how these mutations disrupt protein and RNA functions, contributing to neurodegeneration. Ultimately, their goal is to find new avenues for treatment and intervention for these serious neurological conditions.

Dr. Sergi Regot's lab at Johns Hopkins University focuses on cancer research, particularly how certain genetic changes within tumors can affect cancer growth and response to treatment. They are exploring a protein called TRIM37 and its role in making some cancer cells more vulnerable to specific therapies that target a protein involved in cell division. The aim is to find new ways to treat aggressive cancers, such as breast cancer and neuroblastoma, that show genetic alterations.

Dr. Ashani T Weeraratna's lab focuses on understanding how aging affects melanoma, particularly the way dormant cancer cells can reactivate and spread. The research examines how aged tissues impact tumor behavior and treatment resistance through specific signaling pathways. This work aims to identify new strategies to prevent cancer recurrence, especially in older patients, enhancing the effectiveness of existing therapies.